Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 53
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Wong PPC, Kariminia A, Jones D, Eaves CJ, Foley R, Ivison S, Couban S, Schultz KR | 2018 | Blood | View Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Health care providers | Clinical research |
Pathogen reduction technologies: The pros and cons for platelet transfusion | Magron A, Laugier J, Provost P, Boilard E | 2018 | Platelets | View Pathogen reduction technologies: The pros and cons for platelet transfusion | Blood operators | Basic research |
Platelet-activating antibodies are detectable at the earliest onset of heparin-induced thrombocytopenia, with implications for the operating characteristics of the serotonin-release assay | Warkentin TE, Arnold DM, Kelton JG, Sheppard JI, Smith JW, Nazy I | 2018 | Chest | View Platelet-activating antibodies are detectable at the earliest onset of heparin-induced thrombocytopenia, with implications for the operating characteristics of the serotonin-release assay | Researchers | Clinical research |
Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016 | Vostal JG, Buehler PW, Gelderman MP, Alayash AI, Doctor A, Zimring JC, Glynn SA, Hess JR, Klein H, Acker JP, Spinella PC, D'Alessandro A, Palsson B, Raife TJ, Busch MP, McMahon TJ, Intaglietta M, Swartz HM, Dubick MA, Cardin S, Patel RP, Natanson C, Weisel JW, Muszynski JA, Norris PJ, Ness PM | 2018 | Transfusion | View Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016 | Researchers | New or improved product or process |
Modelling the Need for New Blood Donors Following a Change in Deferral Period | Blake J | 2018 | Industrial Engineering and Operations Management I | View Modelling the Need for New Blood Donors Following a Change in Deferral Period | Researchers | Clinical research |
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. | Cuker A AG, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N | 2018 | Blood Adv | View American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. | Health care providers | Benchmarking and standard setting |
Assessing opportunities and challenges for establishing a national program to distribute cord blood for research | Isasi R, Mastronardi C, Golder M, Allan D, Walker M, Halpenny M, Yang L, Elmoazzen H, Chargé S | 2018 | Transfusion | View Assessing opportunities and challenges for establishing a national program to distribute cord blood for research | Researchers | Other |
GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out | Lewis BJB, Leontyev D, Neschadim A, Blacquiere M, Branch DR | 2018 | Clin Exp Immunol | View GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out | Researchers | Basic research |
The importance of iron for whole blood donors: a Canadian perspective | Pambrun C, Goldman M | 2018 | Blood.ca website | View The importance of iron for whole blood donors: a Canadian perspective | Health care providers | Other |
ResearchUnit: Plasma: what's in the bag? | Sheffield W, Jenkins C | 2018 | Blood.ca website | View ResearchUnit: Plasma: what's in the bag? | Researchers | Basic research |
The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis | Montroy J, Hutton B, Moodley P, Fergusson NA, Cheng W, Tinmouth A, Lavallee LT, Fergusson DA, Breau RH | 2018 | Transfus Med Rev | View The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis | Researchers | Clinical research |
Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire | Chai-Adisaksopha C, Skinner MW, Curtis R, Frick N, Nichol MB, Noone D, O'Mahony B, Page D, Stonebraker J, Thabane L, Crowther M, Iorio A | 2018 | BMJ Open | View Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire | Researchers | Clinical research |
Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia | Guo L, Kapur R, Aslam R, Hunt K, Hou Y, Zufferey A, Speck ER, Rondina MT, Lazarus AH, Ni H, Semple JW | 2018 | Scand J Immunol | View Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia | Researchers | Basic research |
How do we diagnose immune thrombocytopenia in 2018? | Kelton JG VJ, Arnold DM | 2018 | Hematology Am Soc Hematol Educ Program | View How do we diagnose immune thrombocytopenia in 2018? | Health care providers | Clinical research |
Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes | Pierce GF, Iorio A | 2018 | Haemophilia | View Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes | Health care providers | New or improved product or process |
Concurrence of symmetrical peripheral gangrene and venous limb gangrene following polytrauma: a case report | Tan JH, Mohamad Y, Tan CLH, Kassim M, Warkentin TE | 2018 | J Med Case Rep | View Concurrence of symmetrical peripheral gangrene and venous limb gangrene following polytrauma: a case report | Health care providers | Clinical research |
Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | de Wit K | 2018 | CanadiEM website | View Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | Health care providers | Benchmarking and standard setting |
Le déficit en IgA | Goldman M | 2018 | Blood.ca website | View Le déficit en IgA | Health care providers | Benchmarking and standard setting |
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo?controlled trials | Bussel J, Arnold DM, Grossbard E, Mayer J, Treliski J, Homenda W, Hellmann A, Windyga J, Sivcheva L, Khalafallah AA, Zaja F, Cooper N, Markovtsov V, Zayed H, Duliege AM | 2018 | Am J Hematol | View Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo?controlled trials | Health care providers | Clinical research |
Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain | Mistry N, Mazer CD, Sled JG, Lazarus AH, Cahill LS, Solish M, Zhou Y-Q, Romanova N, Hare AGM, Doctor A, Fisher JA, Brunt KR, Simpson JA, Hare GMT | 2018 | Am J Physiol Regul Integr Comp Physiol | View Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain | Researchers | Basic research |
Evaluation of a hydrogel-based diagnostic approach for the point-of-care based detection of Neisseria gonorrhoeae | Perera S, Taheri A, Khan N, Parti R, Stefura S, Skiba P, Acker J, Martin I, Kusalik A, Dillon J-A | 2018 | Antibiotics | View Evaluation of a hydrogel-based diagnostic approach for the point-of-care based detection of Neisseria gonorrhoeae | Researchers | New or improved product or process |
Enhancing the pro-inflammatory anti-cancer T cell response via biomanufactured, secretome-based, immunotherapeutics | Yang X, Kang N, Toyofuku WM, Scott MD | 2018 | Immunobiology | View Enhancing the pro-inflammatory anti-cancer T cell response via biomanufactured, secretome-based, immunotherapeutics | Researchers | Basic research |
Transfusion requirements in cardiac surgery III (TRICS III): study design of a randomized controlled trial | Shehata N, Whitlock R, Fergusson DA, Thorpe KE, MacAdams C, Grocott HP, Rubens F, Fremes S, Lellouche F, Bagshaw S, Royse A, Rosseel PM, Hare G, Medicis E, Hudson C, Belley-Cote E, Bainbridge D, Kent B, Shaw A, Byrne K, Syed S, Royse CF, McGuiness S, Hall J, Mazer CD | 2018 | J Cardiothorac Vasc Anesth | View Transfusion requirements in cardiac surgery III (TRICS III): study design of a randomized controlled trial | Researchers | Clinical research |
Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Lieberman L, Lin Y, Cserti-Gazdewich C, Yi QL, Pendergrast J, Lau W, Callum J | 2018 | Pediatr Blood Cancer | View Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Health care providers | Clinical research |
Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates | Alabdullatif M, Atreya CD, Ramirez-Arcos S | 2018 | Transfusion | View Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates | Researchers | New or improved product or process |
La maladie hémolytique du foetus et du nouveau-né et thrombopénie immune périnatale | Clarke G, Hannon J | 2018 | Guide de la pratique transfusionnelle | View La maladie hémolytique du foetus et du nouveau-né et thrombopénie immune périnatale | Health care providers | Other |
ResearchUnit: How does anti-D prevent hemolytic disease of the fetus and newborn? Lessons from a mouse model | Lazarus A | 2018 | Blood.ca website | View ResearchUnit: How does anti-D prevent hemolytic disease of the fetus and newborn? Lessons from a mouse model | Other | Other |
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Ragni MV, Croteau SE, Morfini M, Cnossen MH, Iorio A | 2018 | J Thromb Haemost | View Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Health care providers | Basic research |
Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Warkentin TE | 2018 | J Thromb Haemost | View Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Health care providers | Benchmarking and standard setting |
Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Adams Z, Morris G, Campbell T, Mostert K, Dibdin N, Fearon M, Elmoazzen H, Mercer D, Young K, Allan D | 2018 | Biol Blood Marrow Transplant | View Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Blood operators | Clinical research |
Splenectomy for immune thrombocytopenia: down but not out | Chaturvedi S, Arnold DM, McCrae KR | 2018 | Blood | View Splenectomy for immune thrombocytopenia: down but not out | Health care providers | Clinical research |
Concentré de recherche : Une façon nouvelle d'évaluer la qualité des globules rouges | Acker J | 2018 | Blood.ca website | View Concentré de recherche : Une façon nouvelle d'évaluer la qualité des globules rouges | Researchers | Clinical research |
Differential diagnoses for sepsis?induced disseminated intravascular coagulation: communication from the SSC of the ISTH | Iba T, Levy J, Wada H, Thachil J, E. Warkentin T, Levi M, Subcommittee on Disseminated Intravascular Coagulation | 2018 | J Thromb Haemost | View Differential diagnoses for sepsis?induced disseminated intravascular coagulation: communication from the SSC of the ISTH | Other | Benchmarking and standard setting |
Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT | Krauel K, Preuße P, Warkentin TE, Trabhardt C, Brandt S, Jensch I, Mandelkow M, Hammer E, Hammerschmidt S, Greinacher A | 2018 | Blood | View Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT | Researchers | Basic research |
Surveillance Report 2017 | O'Brien S | 2018 | Blood.ca website | View Surveillance Report 2017 | Other | Other |
Blood coagulation dissected | Pryzdial ELG, Lee FMH, Lin BH, Carter RLR, Tegegn TZ, Belletrutti MJ | 2018 | Transfus Apher Sci | View Blood coagulation dissected | Health care providers | Other |
Concentré de recherche: Rôle du groupe sanguin dans le déclenchement d'une hémolyse après l'administration d'immunoglobulines | Branch D | 2018 | Blood.ca website | View Concentré de recherche: Rôle du groupe sanguin dans le déclenchement d'une hémolyse après l'administration d'immunoglobulines | Researchers | Basic research |
Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Devine DV | 2018 | JAMA Oncol | View Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Researchers | New or improved product or process |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Plasma components | Health care providers | Benchmarking and standard setting |
Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | MacIsaac J, Siddiqui R, Jamula E, Li N, Baker S, Webert KE, Evanovitch D, Heddle NM, Arnold DM | 2018 | Transfusion | View Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | Researchers | Clinical research |
Therapeutic Apheresis | Pavenski K | 2018 | Clinical Guide to Transfusion | View Therapeutic Apheresis | Health care providers | Benchmarking and standard setting |
Blood bag spiking procedure | Shimla S, Jenkins C, McTaggart K | 2018 | Blood.ca website | View Blood bag spiking procedure | Other | Other |
GPIb? is required for platelet-mediated hepatic thrombopoietin generation | Xu M, Li J, Neves MAD, Zhu G, Carrim N, Yu R, Gupta S, Marshall J, Rotstein O, Peng J, Hou M, Kunishima S, Ware J, Branch DR, Lazarus A, Ruggeri ZM, Freedman J, Ni H | 2018 | Blood | View GPIb? is required for platelet-mediated hepatic thrombopoietin generation | Researchers | Basic research |
Donor deferral policies for men who have sex with men: past, present and future | Goldman M, Shih AW, O'Brien SF, Devine D | 2018 | Vox Sang | View Donor deferral policies for men who have sex with men: past, present and future | Health care providers | MSM research |
Red blood cell antibody induced anemia causes differential degrees of tissue hypoxia in kidney and brain | Mistry N, Mazer CD, Sled JG, Lazarus AH, Cahill LS, Solish M, Zhou Y-Q, Romanova N, Hare AG, Doctor A, Fisher JA, Brunt KR, Simpson JA, Hare GMT | 2018 | Am J Physiol Regul Integr Comp Physiol | View Red blood cell antibody induced anemia causes differential degrees of tissue hypoxia in kidney and brain | Researchers | Basic research |
The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series | Chan TM, Jo D, Shih AW, Bhagirath VC, Castellucci LA, Yeh C, Thoma B, Tseng EK, de Wit K | 2018 | Perspect Med Educ | View The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series | Health care providers | Education research |
Effect of liposome treatment on hemorheology and metabolic profile of human red blood cells during hypothermic storage | Da Silveira Cavalcante L, Acker J, Holovati J | 2018 | Biopreserv Biobank | View Effect of liposome treatment on hemorheology and metabolic profile of human red blood cells during hypothermic storage | Researchers | Basic research |
Pathophysiology of immune thrombocytopenia | Li J, Sullivan JA, Ni H | 2018 | Curr Opin Hematol | View Pathophysiology of immune thrombocytopenia | Researchers | Other |
Importance du fer chez les donneurs de sang total : la perspective canadienne | Pambrun C, Goldman M | 2018 | Blood.ca website | View Importance du fer chez les donneurs de sang total : la perspective canadienne | Health care providers | Other |
rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and FcgammaRs | Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Kasermann F, Zuercher AW | 2018 | J Immunol | View rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and FcgammaRs | Researchers | Basic research |